During the past decade, William Beaumont Hospital Research Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "William Beaumont Hospital Research Institute" #1 sponsor was "Allergan" with 2 trials, followed by "C. R. Bard" with 1 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials sponsored, "NuVasive" with 1 trials sponsored and "Rutgers, The State University of New Jersey" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "William Beaumont Hospital Research Institute" #1 collaborator was "Cianna Medical, Inc." with 1 trials as a collaborator, "Elekta Limited" with 1 trials as a collaborator and "Rutgers Cancer Institute of New Jersey" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "William Beaumont Hospital Research Institute" are "Urinary Incontinence" (2 trials), "Cervical Degenerative Disc Disorder" (1 trials), "Chromosome Abnormalities" (1 trials), "Down Syndrome" (1 trials) and "Ductal Breast Carcinoma In Situ" (1 trials). Many other conditions were trialed in "William Beaumont Hospital Research Institute" in a lesser frequency.

Most popular intervention types in "William Beaumont Hospital Research Institute" are "Biological" (2 trials), "Device" (2 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "OnabotulinumtoxinA" (2 trials), "Accelerated Partial Breast Irradiation" (1 trials), "High-Dose Rate Brachytherapy" (1 trials), "Lutonix DCB" (1 trials) and "Questionnaire Administration" (1 trials). Other intervention names were less common.

The vast majority of trials in "William Beaumont Hospital Research Institute" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "William Beaumont Hospital Research Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in William Beaumont Hospital Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in William Beaumont Hospital Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

William Beaumont Hospital Research Institute has several departments that took part in Clinical trials: "Beaumont Children's Hospital-Royal Oak" - 65 trials, "William Beaumont Hospital Urology Research" - 6 trials, "William Beaumont Hospital - Royal Oak Campus - Infectious Disease" - 4 trials, "Oakwood Hospital/Cancer Center" - 3 trials, "Clinical Neuroscience Center" - 3 trials, "Beaumont Women's Urology Center" - 2 trials, "Beaumont Cancer Center" - 2 trials, "Beaumont Pediatric Neurology" - 2 trials